Iterum Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Iterum Therapeutics has a total shareholder equity of $3.4M and total debt of $19.6M, which brings its debt-to-equity ratio to 570.9%. Its total assets and total liabilities are $39.7M and $36.3M respectively.
Key information
570.9%
Debt to equity ratio
US$19.59m
Debt
Interest coverage ratio | n/a |
Cash | US$35.89m |
Equity | US$3.43m |
Total liabilities | US$36.30m |
Total assets | US$39.73m |
Recent financial health updates
Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
Aug 19Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
May 06Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
Jan 12Is Iterum Therapeutics (NASDAQ:ITRM) A Risky Investment?
Sep 25Recent updates
Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
Aug 19Iterum Therapeutics Non-GAAP EPS of -$0.03 beats by $0.03
Aug 12Iterum jumps 64% as FDA agrees to Phase 3 trial for UTI candidate
Jul 11Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
May 06Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
Jan 12Is Iterum Therapeutics (NASDAQ:ITRM) A Risky Investment?
Sep 25Despite Risks Around Regulatory Approval, Iterum Therapeutics Rates A Speculative Buy
Jul 05It's Unlikely That The CEO Of Iterum Therapeutics plc (NASDAQ:ITRM) Will See A Huge Pay Rise This Year
Jun 11Is Iterum Therapeutics (NASDAQ:ITRM) Using Debt Sensibly?
May 20Have Insiders Been Selling Iterum Therapeutics plc (NASDAQ:ITRM) Shares?
Feb 04This Insider Has Just Sold Shares In Iterum Therapeutics plc (NASDAQ:ITRM)
Feb 04Iterum Therapeutics shares slide 13% on raising $10M
Feb 03Iterum Therapeutics rises 39% on RA Capital stake disclosure
Dec 03Iterum Therapeutics files US application for sulopenem in urinary tract infections
Nov 30Iterum Therapeutics EPS beats by $0.45
Nov 16Financial Position Analysis
Short Term Liabilities: ITRM's short term assets ($38.5M) exceed its short term liabilities ($16.4M).
Long Term Liabilities: ITRM's short term assets ($38.5M) exceed its long term liabilities ($19.9M).
Debt to Equity History and Analysis
Debt Level: ITRM has more cash than its total debt.
Reducing Debt: ITRM's debt to equity ratio has increased from 15.5% to 570.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ITRM has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ITRM has less than a year of cash runway if free cash flow continues to grow at historical rates of 19.8% each year.